Jackson Square Capital, LLC Eli Lilly & CO Transaction History

Jackson Square Capital, LLC

$381 Million
Q3 2024

A detailed history of Jackson Square Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jackson Square Capital, LLC holds 22,877 shares of LLY stock, worth $17.1 Million. This represents 5.32% of its overall portfolio holdings.

Number of Shares

22,877

Previous 24,195 5.45%

Holding current value

$17.1 Million

Previous $21.9 Million 7.48%

% of portfolio

5.32%

Previous 5.66%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $1.02 Million - $1.27 Million	-1,318 Reduced 5.45%	22,877 $20.3 Million
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $81,185 - $101,812	112 Added 0.47%	24,195 $21.9 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $20,727 - $27,729	35 Added 0.15%	24,083 $18.7 Million
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $53,044 - $62,532	-101 Reduced 0.42%	24,048 $14 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $211,264 - $291,259	486 Added 2.05%	24,149 $13 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $734,800 - $982,513	-2,095 Reduced 8.13%	23,663 $11.1 Million
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $636,480 - $747,516	2,049 Added 8.64%	25,758 $8.85 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $217,046 - $252,902	-675 Reduced 2.77%	23,709 $0
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $191,229 - $217,926	-645 Reduced 2.58%	24,384 $7.89 Million
Q2 2022 Jul 25, 2022	BUY	$278.73 - $327.27 $152,744 - $179,343	548 Added 2.24%	25,029 $8.12 Million
Q1 2022 Apr 20, 2022	BUY	$234.69 - $291.66 $425,492 - $528,779	1,813 Added 8.0%	24,481 $7.01 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $110,626 - $137,287	492 Added 2.22%	22,668 $6.26 Million
Q3 2021 Oct 21, 2021	SELL	$221.6 - $272.71 $7,977 - $9,817	-36 Reduced 0.16%	22,176 $5.12 Million
Q2 2021 Jul 20, 2021	SELL	$180.55 - $233.54 $49,831 - $64,457	-276 Reduced 1.23%	22,212 $5.1 Million
Q1 2021 May 18, 2021	BUY	$164.32 - $212.72 $713,148 - $923,204	4,340 Added 23.91%	22,488 $4.2 Million
Q4 2020 Mar 05, 2021	SELL	$130.46 - $172.63 $329,281 - $435,718	-2,524 Reduced 12.21%	18,148 $3.06 Million
Q3 2020 Nov 17, 2020	BUY	$146.22 - $169.13 $136,277 - $157,629	932 Added 4.72%	20,672 $3.06 Million
Q2 2020 Aug 18, 2020	BUY	$136.42 - $164.18 $1.12 Million - $1.35 Million	8,234 Added 71.56%	19,740 $3.24 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $188,813 - $233,697	1,586 Added 15.99%	11,506 $1.6 Million
Q4 2019 May 15, 2020	BUY	$106.92 - $132.43 $1.06 Million - $1.31 Million	9,920 New	9,920 $1.3 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.

Account

Jackson Square Capital, LLC Eli Lilly & CO Transaction History